Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Giada Pinterpe
Observed names:
G Pinterpe,
G. Pinterpe
Institutions:
Marche Polytechnic University,
Azienda Ospedaliero-Universitaria delle Marche
Observed institutions:
Marche Polytechnic University,
Agostino Gemelli University Polyclinic,
San Salvatore Hospital,
Azienda Ospedaliero-Universitaria delle Marche,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0000-0001-9395-2104
Observed ORCID:
0000-0001-9395-2104
OpenAlex ID:
A5081721442
The Landscape of ALK-Rearranged Non-Small Cell Lung Cancer: A Comprehensive Review of Clinicopathologic, Genomic Characteristics, and Therapeutic Perspectives
2022
·
Valeria Cognigni
, Federica Pecci
, et al.
·
Cancers
·
52
PDF
Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study
2022
·
Giulia Mentrasti
, Luca Cantini
, et al.
·
The Oncologist
·
33
PDF
Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies
2024
·
Alessandro Parisi
, Blandine Delaunay
, et al.
·
European Journal of Cancer
·
30
PDF
Impact of Signet-Ring Cell Histology in the Management of Patients with Non-Metastatic Gastric Cancer: Results from a Retrospective Multicenter Analysis Comparing FLOT Perioperative Chemotherapy vs. Surgery Followed by Adjuvant Chemotherapy
2023
·
Riccardo Giampieri
, Maria Giuditta Baleani
, et al.
·
Cancers
·
18
PDF
Defining the Position of [177Lu]Lu-PSMA Radioligand Therapy in the Treatment Landscape of Metastatic Castration-Resistant Prostate Cancer: A Meta-analysis of Clinical Trials
2024
·
Chiara Ciccarese
, Matteo Bauckneht
, et al.
·
Targeted Oncology
·
17
Seroprevalence of SARS-CoV-2–Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy
2021
·
Luca Cantini
, Lucia Bastianelli
, et al.
·
Journal of Clinical Medicine
·
13
PDF
Predictive Ability for Disease-Free Survival of the GRade, Age, Nodes, and Tumor (GRANT) Score in Patients with Resected Renal Cell Carcinoma
2020
·
Alessio Cortellini
, Sebastiano Buti
, et al.
·
Current Urology
·
11
Joint survey by AIMN, AIOM, AIRO, SIU, SIUrO, and Meet-URO about the use of PSMA PET imaging in prostate cancer in Italy: technical aspects and primary staging setting
2025
·
Matteo Bauckneht
, Laura Evangelista
, et al.
·
Clinical and Translational Imaging
·
8
PDF
Hemoglobin and Neutrophil Count as Prognostic Factors in Cholangiocarcinoma Patients in 2nd Line Treatment Setting: Results from a Small Monocentric Retrospective Study
2023
·
Carolina Liguori
, Cecilia Copparoni
, et al.
·
Current Oncology
·
4
PDF
Joint survey by AIMN, AIOM, AIRO, SIU, SIUrO, and Meet-URO about the use of PSMA PET imaging in prostate cancer in Italy: PSA persistence, biochemical recurrence, hormone-sensitive and castration-resistant metastatic settings
2026
·
Matteo Bauckneht
, Laura Evangelista
, et al.
·
Clinical and Translational Imaging
·
3
PDF
The Impact of Uncommon HRR Alterations as Predictors of Efficacy of PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials
2025
·
Giada Pinterpe
, Fortuna Migliaccio
, et al.
·
Targeted Oncology
·
3
Cardiotoxicity of Antitumor Agents: Therapeutic Challenges in Heart Failure with Reduced and Preserved Ejection Fraction
2026
·
Marco Tana
, Rachele Piccinini
, et al.
·
International Journal of Molecular Sciences
·
2
PDF
228eP ABCA1 and ABCG1 cholesterol transporters expression on metastatic renal cell carcinoma, blood cholesterol and triglycerides, CONUT score: Impact on immunotherapy outcomes (CHOMET study)
2025
·
G.C. Giudice
, M. Maffezzoli
, et al.
·
Annals of Oncology
·
2
Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients
2021
·
Alessandro Bittoni
, Riccardo Giampieri
, et al.
·
Current Oncology
·
2
PDF
35P Lung cancer diagnosis and continuum of care: How did the COVID-19 outbreak impact? Data from an Italian multicenter study
2021
·
L. Cantini
, G. Mentrasti
, et al.
·
Journal of Thoracic Oncology
·
2
PDF
Re: Thomas Powles, Zoe June Assaf, Viraj Degaonkar, et al. Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma. Eur Urol 2024;85:114–22
2024
·
Viria Beccia
, Giada Pinterpe
, et al.
·
European Urology
·
1
External validation of prognostic ALAN score in patients with inoperable bile duct cancer treated with second-line chemotherapy
2021
·
R. Giampieri
, C. Liguori
, et al.
·
Annals of Oncology
·
1
Cholesterol transporters and immune-metabolic features in patients with metastatic renal cell carcinoma receiving immunotherapy combinations
2026
·
Giulia Claire Giudice
, Hassan Mohammed Abushukair
, et al.
·
The Oncologist
PDF
Prognostic Impact of Concomitant Genomic Alterations in FGFR2 ‐Positive Cholangiocarcinoma Treated With Pemigatinib
2026
·
Carolina Liguori
, Riccardo Giampieri
, et al.
·
Liver International
PSMA PET is no longer a matter of evidence, but a matter of access and sustainability: Insights from an Italian multidisciplinary survey in a European perspective
2026
·
Matteo Bauckneht
, Laura Evangelista
, et al.
·
The EANM Journal
PDF
Impact of immunotherapy in patients with upper tract urothelial carcinoma: a meta-analysis of randomized trials
2026
·
Denis Occhipinti
, CHIARA CICCARESE
, et al.
·
SSRN Electronic Journal
PDF
Prognostic impact of ABCA1/ABCG1 expression, lipid parameters, and nephrectomy in patients with renal cell carcinoma receiving immune checkpoint inhibitors
2025
·
G C Giudice
, M Maffezzoli
, et al.
·
The Oncologist
Pemigatinib-associated toxicity and its management: implications on prognosis in patients with cholangiocarcinoma treated within real-world Italian PEMIREAL and French PEMIBIL cohorts
2025
·
Riccardo Giampieri
, Carolina Liguori
, et al.
·
SSRN Electronic Journal
Highlights from the 2024 ASCO Genitourinary Symposium: focus on urothelial and prostate cancer
2024
·
Alessandro Strusi
, Giada Pinterpe
, et al.
·
Expert Review of Anticancer Therapy
1616P Drop in early-stage colorectal cancer diagnoses after COVID-19: Preliminary report from the COVID-DELAY study
2021
·
G. Mentrasti
, V. Cognigni
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
25
Citation count:
202
H-index:
8
I10-index:
7
Year
Topic
Type